Drug Profile
6-fluoro-18[F]-L-DOPA - Advanced Accelerator Applications
Alternative Names: DOPAVIEWLatest Information Update: 15 Jul 2019
Price :
$50
*
At a glance
- Originator Advanced Accelerator Applications
- Class Diagnostic agents; Imaging agents
- Mechanism of Action Positron-emission tomography enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Parkinson's disease
Most Recent Events
- 01 Feb 2018 Advanced Accelerator Applications has been acquired by Novartis